LGVN
Companies
NASDAQ
Longeveron Inc.
Health Care
$1.21
-$0.53 (-30.64%)
Price Chart
Overview
About LGVN
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Cap
$6.6M
Volume
134.3K
Avg. Volume
439.9K
P/E Ratio
-0.88235295
Dividend Yield
0.00%
Employees
25.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.86
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LGVN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$6.6M
Volume134.3K
P/E Ratio-0.88
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025